Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

JULY 1, 2022

We are currently recruiting for a Program Analyst to develop, coordinate, and analyze our tracking systems. The position will be developing and evaluating OPS’s Training program, Licensing and Compliance (TLC) system as well as OPS’s product tracking system. Research and recommend systems, policies, and operations.

Programs 52

Programs Compliance Compliance Research and Development 52

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Scientific research supports the potential of cannabinoids in regulating blood sugar levels, weight management, and addressing diabetic neuropathy.

Research and Development 108

Research and Development Consumption Education Data 108

Canna Care Docs

OCTOBER 10, 2024

Rescheduling would stand to have the largest impact on cannabis research and business taxes. Cannabis research The Controlled Substances Act requires scientists to register with the DEA if they want to research Schedule I substances. What does rescheduling cannabis mean for medical cannabis patients?

Patients 111

Patients DEA Research and Development Recreational 111

Cannabis Law Report

DECEMBER 21, 2021

Hemp4Soil Program will Create Innovative Approaches and Technologies in Partnership with Farms Across America. Heartland’s ‘Hemp4Soil’ program was selected as the recipient of a $360,000 grant over 3 years to develop their soil innovation program. Heartland was the only hemp program chosen by the USDA.

Agriculture 52

Agriculture Supply Chain Research and Development Programs 52

SpeedWeed

JULY 23, 2021

The immersive, multisensory curriculum will enable customers and growers to expand their knowledge of how to apply novel scientific research, interpret cultivation data and leverage Agrify’s technology to improve their indoor cannabis cultivation practices. BILLERICA, Mass.,

Programs 52

Programs Research and Development Data Cultivation 52

Cannabis Law Report

SEPTEMBER 23, 2021

This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program. Awakn will now be able to accelerate its clinical research into a phase IIb randomized controlled trial (RCT) in the U.K. . – September 23, 2021) – Awakn Life Sciences Corp., (NEO:

Research and Development 52

Research and Development Therapy Treatment Data 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. Research published in 2016 revealed that 59% of a sample of patients who misused opioids were first exposed to them through a medical prescription.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

JULY 1, 2021

The bill, now signed into law, includes numerous patient-focused updates to the Pennsylvania Medical Marijuana Program , the majority of which became effective immediately upon the Governor’s signing. of House members.

Programs 85

Programs Supply Chain Research and Development Marijuana 85

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . Pivoting on New Product Development. .

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

Cannabis Law Report

MAY 9, 2022

Preferred candidates will have seven years prior experience in a policy-related management role; experience with professional exposure to the cannabis industry or policy issues related to public health and safety; experience with a strong analytical background and experience working with large data sets.

Policy 52

Policy Research and Development Safety Data 52

SpeedWeed

APRIL 30, 2021

The German government is now funding cannabis research on cannabinoid extractions and additives to food. It is even more interesting to understand that the federal government program behind this is no less than the Federal Ministry of Economics and Energy—which is as about as central to German economic investment in the future as you can get.

Extraction 52

Extraction CBD Research and Development Food 52

The Joint Blog

JUNE 8, 2020

We continue to explore and report on new cannabis related university and certification programs that are popping up around the world to help meet the demand of employment for the sector. Interpret data to assess crop health and quality and adapt to growth conditions/pest management strategies. And much more!

Programs 32

Programs Research and Development Environment Packaging 32

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Market research helps identify trends and shifts in consumer preferences, allowing businesses to tailor their offerings accordingly.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

MARCH 17, 2022

Data Manager. The Data Manager, under the direction of the Director of Data Analytics, will be responsible for managing, manipulating, analyzing, and modeling data to support the Commission’s research agenda, licensing, and compliance decisions. Request for Responses (RFR): External Research Review.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

OCTOBER 29, 2021

Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use. October 27, 2021. Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin. DENVER, Oct.

Pharmaceutical 52

Pharmaceutical Research and Development Data Safety 52

Cannabis Law Report

MARCH 10, 2022

Breaking from past tradition, this year’s Industrial Hemp Summit was held at the North Carolina Biotechnology Center in the Research Triangle Park. Domestic Hemp Production Program at the U.S. It is clear that he and his staff are committed to the continued growth and development of a viable domestic U.S.

Hemp 52

Hemp Research and Development Supply Chain Data 52

Cannabis Law Report

OCTOBER 12, 2021

The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Contact: Mike Munzer, 631-240-8814, mike.munzer@adnas.com Web: www.adnas.com Twitter: @APDN.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 15, 2021

a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

The Cannigma

AUGUST 5, 2022

But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” ” 8 9.

Treatment 140

Treatment Research and Development Therapy Digestion 140

Cannabis Law Report

NOVEMBER 9, 2021

Pavel Otáhal, contributing author and Head of the Gene Immunotherapy Research Department at ÚHKT, stated, “Our study compares the manufacture of CAR19 T-cells via PCR-made transposon DNA (LinearDNA) with mRNA encoding of the transposase against a conventional plasmid approach. Dr. James A. About LineaRx, Inc.,

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Program between St. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

NOVEMBER 22, 2021

Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Headset’s data shows that medical cannabis consumers tend to spend more money in order to purchase a larger supply at one time.

Recreational 98

Recreational Data Dispensary Medicine 98

SpeedWeed

SEPTEMBER 17, 2021

“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 144

Research and Development Treatment Chronic Pain Sleep 144

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

AUGUST 22, 2021

With decriminalization efforts underway in many other cities and states, this new training, the first of its kind in the US, could set the stage for the design and deployment of programs like it across the country. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105